Research Articles | Page 87 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis Dec 2019 Leukemia myelodysplastic syndromes (MDS)
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison? May 2013 Leukemia myelodysplastic syndromes (MDS)
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents Jan 2013 Leukemia myelodysplastic syndromes (MDS)
Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron May 2014 Leukemia myelodysplastic syndromes (MDS)
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides Oct 2015 Leukemia
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Therapy-related Myelodysplastic Syndromes Deserve Specific Diagnostic Sub-Classification and Risk-Stratification-An Approach to Classification of Patients With t-MDS Jun 2020 Leukemia myelodysplastic syndromes (MDS)
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Share with addtoany.com.